T1	p 53 100	patients insufficiently controlled on timolol .
T2	p 241 307	patients with open angle glaucoma or ocular hypertension where IOP
T3	p 426 585	. 53 patients with primary open angle glaucoma , capsular glaucoma , or ocular hypertension with an IOP of at least 21 mmHg on current therapy were recruited .
T4	i 38 49	latanoprost
T5	i 91 98	timolol
T6	i 167 237	switching from timolol to latanoprost or adding latanoprost to timolol
T7	i 342 349	timolol
T8	i 475 483	capsular
T9	i 631 638	timolol
T10	i 711 712	.
T11	i 736 786	timolol , one switched from timolol to latanoprost
T12	i 821 826	third
T13	i 833 878	received latanoprost in addition to timolol .
T14	i 1126 1133	timolol
T15	i 1208 1219	latanoprost
T16	i 1318 1329	latanoprost
T17	i 1333 1340	timolol
T18	i 1408 1415	timolol
T19	i 1419 1430	latanoprost
T20	i 1578 1589	latanoprost
T21	i 1614 1621	timolol
T22	i 1695 1702	timolol
T23	i 1706 1717	latanoprost
T24	o 135 176	intraocular pressure ( IOP ) of switching
T25	o 883 891	efficacy
T26	o 919 922	IOP
T27	o 984 987	IOP
T28	o 1349 1352	IOP
T29	o 1439 1442	IOP
T30	o 1522 1535	IOP reduction
T31	o 1645 1658	IOP reduction